Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


About the Study

Who runs this study?

Dr Cornelia Cudrici is a Staff Clinician/Associate Research Physician in Dr. Manfred Boehm's Laboratory of Cardiovascular Regenerative Medicine at the Center for Molecular Medicine, in the Translational Vascular Medicine Branch (TVMB) with National Heart, Lung, and Blood Institute (NHLBI). She received her medical degree from University of Medicine and Pharmacy "Iuliu Hatieganu" Medical School, Cluj-Napoca, Romania then completed a residency in Internal Medicine at Rochester General Hospital in Rochester, NY and Rheumatology fellowship at National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) at National Institutes of Health (NIH) in Bethesda, MD. Her research mainly focuses on studying rare blood vessel diseases, including conditions that cause inflammation in blood vessels. She is interested in finding new markers for these diseases, understanding the immune system's role, particularly on patients with Köhlmeier-Degos disease and to conduct clinical trials with these patients.

What is this study about?

Dr. Cudrici's team is now investigating if Baricitinib halts the progression of brain radiological findings for patient with neurological involvement of their Degos disease. The goal of this study is to test if Baricitinib is able to delay these effects while also testing if this treatment improves patient-reported outcomes.

How can I ask questions or ask for help?

Email us at TVMBTeam@nih.gov (or click on Contact). It may take us up to 5 business days to back to you.